Invited Review: Compounding parenteral nutrition: Reducing the risks

Nutrition in Clinical Practice

Volumn 24, Issue 4, 2009, Pages 441-446

  Curtis, Caitlin ^a   Sacks, Gordon S ^b  

^a University of Wisconsin Health   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Drug compounding; Drug packaging; Parenteral nutrition; Pharmaceutical preparations; Total

Indexed keywords

AUTOMATION; CLEANING; CONTAMINATION; EVIDENCE BASED MEDICINE; MEDICAL LITERATURE; PARENTERAL NUTRITION; PARTICULATE MATTER; PHARMACY; QUALITY CONTROL; REVIEW; RISK REDUCTION; TRAINING; UNITED STATES; DRUG CONTAMINATION; DRUG FORMULATION; DRUG LABELING; DRUG STORAGE; HEALTH CARE QUALITY; HOSPITAL PHARMACY; HUMAN; METHODOLOGY; PRACTICE GUIDELINE; STANDARD;

DRUG COMPOUNDING; DRUG CONTAMINATION; DRUG LABELING; DRUG STORAGE; GUIDELINES AS TOPIC; HUMANS; PARENTERAL NUTRITION; PHARMACOPOEIAS AS TOPIC; PHARMACY SERVICE, HOSPITAL; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 70349572649     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533609339070     Document Type: Review

References (10)

1. Chapter <797> Pharmaceutical compounding-sterile preparations. In: Revision Bulletin, The United States Pharmacopeia. Rockville, MD: The United States Pharmacopeial Convention ; 2008: 1-61.
2. Campos L., Lobianco L., Seki L., Santos RM, Asensi MD Outbreak of Enterobacter hormaechei septicaemia in newborns caused by contaminated parenteral nutrition in Brazil. J Hosp Infect. 2007 ; 66: 95-97.
3. Habsah H., Zeehaida M., Van Rostenberghe H., et al. An outbreak of Pantoea spp in a neonatal intensive care unit secondary to contaminated parenteral nutrition. J Hosp Infect. 2005 ; 61: 213-218.
4. Marais E., Stewart R., Duse A., Rosekilly IC, de Jong G., Aithma N. Candida parapsilosis detected in TPN using the BacT/Alert system and characterized by randomly amplified polymorphic DNA. J Hosp Infect. 2004 ; 56: 291-296.
5. Selenic D., Dodson D., Jensen B., Arduino MJ, Panlilio A., Archibald LK Enterobacter cloacae bloodstream infections in pediatric patients traced to a hospital pharmacy. Am J Health Syst Pharm. 2003 ; 60: 1440-1446.
6. TheASHPDiscussionGuideonUSPChapter<797>forCompounding Sterile Preparations: Summary of Revisions to USP Chapter <797>, developed by the American Society for Health-System Pharmacists in collaboration with Baxter Healthcare Corporation. Bethesda, MD: ASHP, Inc.
7. U.S. Food and Drug Administration. Compliance policy guides manual. Sec. 460.200 pharmacy compounding. Reissued May 29, 2002. http://www.fda.gov/ora/ compliance-ref/cpg/cpgdrg/cpg460-200.html. Accessed January 29, 2009.
8. American Society of Health-System Pharmacists. ASHP guidelines on the safe use of automated compounding devices for the preparation of parenteral nutrition admixtures. Am J Health Syst Pharm. 2000 ; 57: 1343-1348.
9. Two children die after receiving infected TPN solutions. Pharm J. 1994 ; 252: 596.
10. Mirtallo J., Canada T., Johnson D., et al. Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition [published correction appears in JPEN J Parenter Enteral Nutr. 2006;30:177]. JPEN J Parenter Enteral Nutr. 2004 ; 28: S39 - S70.